FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors - FDA Press Releases

FDA approves treatment for the control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.

from FDA Press Releases RSS Feed https://ift.tt/342D6yx
via IFTTT